This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMelanoma and MAPK Pathways · Cutaneous Melanoma Detection and Management · PI3K/AKT/mTOR signaling in cancer
Following the publication of this article [1], concerns were raised regarding results presented in Fig 2 of [1] that appear similar to results previously published under a CC-BY 4.0 license in [2] by a different author group. Specifically,
One of the corresponding authors (SI) stated that the panel overlap was the result of a clerical error and provided underlying data for editorial review. However, the data and response provided were not sufficient to resolve the issues raised with this article.
The above concerns call into question the reliability and provenance of the results. Therefore, the PLOS ONE Editors retract this article.
MM, SI, and QLW agreed with the retraction and apologize for the issues with the article. WM, ZW, II, MDS, YZ, QW, and JF either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Ma W, Wu Z, Maghsoudloo M, Ijaz I, Dehghan Shasaltaneh M, Zhang Y, et al. (2023) Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways. P Lo S ONE 18(7): e 0285806. 10.1371/journal.pone.0285806 37432950 PMC 10335698 · doi ↗ · pubmed ↗
- 2Hu Q, Li Y, Chen H, Liao H, He Y, and Zheng Q (2022). CCDC 88A Post-Transcriptionally Regulates VEGF via mi R-101 and Subsequently Regulates Hepatocellular Carcinoma. Frontiers in Immunology, 13:859331. 10.3389/fimmu.2022.859331 35493459 PMC 9043556 · doi ↗ · pubmed ↗